Call for innovations to reduce child deaths

Glaxosmithkline (GSK) and Save the Children announced the launch of their third annual $1 million Healthcare Innovation Award that rewards innovations in healthcare that have helped to reduce child deaths in developing countries.

From the 15 July – 7 September 2015, organisations from across developing countries can nominate examples of innovative health approaches they have implemented. These approaches must have resulted in tangible improvements to under-5 child survival rates, be sustainable and have the potential to be scaled-up and replicated.

With millions of people still lacking access to basic healthcare, this year, there will be a special focus on innovations that aim to strengthen developing country health systems and have proven to help increase access to public healthcare for pregnant women, mothers and children under five.

Strengthening health systems for everyone in developing countries is an integral element of GSK and Save the Children's partnership, which champions universal health coverage to help ensure equitable, accessible healthcare for all.

As well as providing funding, this year's Healthcare Innovation Award will provide a platform to review and evaluate new approaches to health system challenges, to recognise those that are having an impact, and share their learnings with the wider global health community.